Summary
Sera from seven patients with bronchogenic carcinoma and cerebellar dysfunction were tested for anti-Purkinje cell antibodies (APCA) by indirect immunofluorescence and indirect immunoperoxidase reaction. Specific APCA as described in paraneoplastic cerebellar degeneration (PCD) were not detected in any of these patients or in control patients. The lack of APCA in patients with bronchogenic carcinoma and their presence in association with ovarian or breast cancer indicate that different pathogenetic mechanisms may play a role in PCD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anderson NE, Budde-Steffen C, Wiley RG, Thurman L, Nadeau SE, Posner JB (1987) Atypical anti-Purkinje cell antibody in paraneoplastic cerebellar degeneration. Neurology [Suppl] 37:285
Arnason BGW (1979) Paraneoplastic syndromes of muscle, nerve and brain: immunological considerations. In: Rose FC (ed) Clinical neuroimmunology. Blackwell Scientific, Oxford
Babikian V, Stefansson K, Manton LS, Liebermann F, Arnason BGW (1984) Antibodies against antigens shared by an oat-cell tumor and neural tissue in the serum of a patient with paraneoplastic disorder of peripheral nerve and spinal cord. Neurology [Suppl] 34:186
Brown RH, Ronthal M, Come S, Abend W, Sotrel A, Ogonowski M, Weiner HL (1985) Antibodies to 85,000 dalton protein in paracarcinomatous cerebellar degeneration. Neurology [Suppl] 35:288
Cunningham J, Graus F, Anderson N, Posner JB (1986) Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology 36:1163–1168
Graus F, Cordon-Cardo C, Posner JB (1985) Neuronal anti-nuclear antibody in sensory neuronopathy from lung cancer. Neurology 35:538–543
Greenlee JE, Brashear HR (1983) Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol 14:609–613
Greenlee JE, Sun M (1984) Variable immunofluorescent staining of nonhuman cerebellar tissue with sera from patients with paraneoplastic cerebellar degeneration: a cautionary tale. Neurology [Suppl] 34:88
Greenlee JE, Brashear HR, Jaeckle KA, Stroop WG (1986) Anti-cerebellar antibodies in sera of patients with paraneoplastic cerebellar degeneration: studies of antibody specificity and response to plasmapheresis. Ann Neurol 20:139
Henson RA, Urich H (1982) Cortical cerebellar degeneration. In: Henson RA, Urich H (eds) Cancer and nervous system. Blackwell, Oxford
Jaeckle KA, Graus F, Houghton A, Cordon-Cardo C, Nielsen SL, Posner JB (1985) Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen. Ann Neurol 18:592–600
Newsom-Davis J (1985) Lambert-Eaton myasthenic syndrome. Springer Semin Immunopathol 8:129–140
Stefansson K, Antel JP, Wollmann RL, Levin KH, Larson R, Arnason BGW (1981) Anti-neuronal antibodies in serum of a patient with Hodgkin disease and cerebellar ataxia. Neurology 31:126
Steven MM, Mackay IR, Carnegie PR, Bhathal PS, Anderson RM (1982) Cerebellar cortical degeneration with ovarian carcinoma. Postgrad Med J 58:47–51
Tanaka K, Yamazaki M, Sato S, Toyoshima I, Yamamoto A, Miyatake T (1986) Antibodies to brain proteins in paraneoplastic cerebellar degeneration. Neurology 36:1169–1172
Trotter JL, Hendin BA, Osterland CK (1976) Cerebellar degeneration with Hodgkin disease. Arch Neurol 33:660–661
Wessel K, Diener HC, Dichgans J, Thron A (1988) Cerebellar dysfunction in patients with bronchogenic carcinoma: clinical and posturographic findings. J Neurol 235:290–296
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wessel, K., Budde-Steffen, C., Wiethölter, H. et al. Cerebellar dysfunction in patients with bronchogenic carcinoma: immunological investigations. J Neurol 235, 297–299 (1988). https://doi.org/10.1007/BF00314177
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314177